Unlike the healing peptides discussed above, Tesamorelin directly influences fat metabolism through growth hormone releasing hormone (GHRH) receptor activation
It is not approved in the treatment of primary hyperparathyroidism (caused by a parathyroid tumor) because it is harmful
They are not intended for human or animal consumption , nor for use in food, drugs, medical devices, or cosmetics
Serious side effects include muscle weakness, extreme thirst, confusion, shortness of breath, headache, exhaustion, reddening of the skin, and a fast or irregular heartbeat
Each element reinforces the others, creating a researcher experience that Swiss Chems alternatives searches increasingly recognize as the industry standard to measure against